World's First Objective Test For Mental Health
Medibio’s patent pending technology can potentially revolutionize the diagnosis and treatment of mental health.
Medibio’s technology may also help revolutionize stress management.
Its technology is based on 15 years’ research on the relationship between circadian heart rate variability (CHR-V) and psychological states.
|350 million worldwide diagnosed with depression
1 suicide every 40 seconds = 1 million suicides every year,
Global annual cost of mental health disorders estimated at $US2.5 trillion with depression and anxiety accounting for more than 50% of the cost burden